Humanetics Executive and Leadership Team

Amit Singhi, the Chief Financial Officer at Humanetics, directs all financial operations and fiscal strategy. Singhi oversees budgeting, financial planning, and resource allocation, ensuring robust financial health to support the company's clinical-stage drug development pipeline. This leadership role involves managing investor relations and securing capital necessary for accelerated discovery and commercialization efforts. By optimizing financial structures, Amit Singhi directly supports the company's focus on medical countermeasures and radiation modulators. The Chief Financial Officer's strategic financial management is critical for navigating the complexities of pharmaceutical development and achieving market penetration in areas with urgent, unmet medical needs. Singhi's oversight ensures that all financial activities align with Humanetics' mission to bring innovative therapies to patients.

Karsten Newbury, the President, Humanetics Digital at Humanetics, spearheads the strategic direction and operational execution of all digital business units. Newbury drives the integration of digital technologies across the organization to optimize the discovery, development, and commercialization of proprietary drugs. This leadership position involves fostering innovation within the digital arm, ensuring alignment with the company's core mission to address urgent unmet needs. By guiding digital strategy, Karsten Newbury enhances the company's capabilities in developing medical countermeasures and radiation modulators for oncology and inflammatory lung diseases. The President's focus on digital expansion is crucial for maximizing market impact and patient access to novel therapies. Newbury's oversight ensures that Humanetics Digital remains at the forefront of technological advancement in the pharmaceutical sector.

Barnaby Loehnis, the President, Humanetics Sensors at Humanetics, directs the strategic growth and operational excellence of the sensor division. Loehnis oversees the development and deployment of advanced sensor technologies that support the company's broader pharmaceutical objectives. This role involves leading innovation in sensor design and application, ensuring these technologies contribute to the accelerated discovery and development of proprietary drugs. By managing the sensor business, Barnaby Loehnis enhances Humanetics' capacity to address urgent market needs, particularly in areas like medical countermeasures and radiation modulators. The President's focus on sensor technology is critical for advancing research in oncology and inflammatory lung diseases. Loehnis's leadership ensures that Humanetics Sensors provides essential technological components for the company's innovative therapeutic pipeline.

Barney Loehnis, the President, Humanetics Sensors at Humanetics, drives the strategic vision and market expansion for the sensor technologies division. Loehnis manages the integration of cutting-edge sensor solutions that bolster the company's capabilities in drug discovery and development. This executive position focuses on optimizing the performance and application of sensors to meet urgent market demands, particularly for medical countermeasures and radiation modulators. By leading the sensor business, Barney Loehnis ensures alignment with Humanetics' mission to combat oncology and inflammatory lung diseases. The President's commitment to technological advancement in sensors is vital for supporting the company's pipeline of innovative pharmaceuticals. Loehnis's strategic oversight strengthens Humanetics' position as a leader in addressing critical health challenges.

Sandra Coleman, the Chief Technology Officer, Humanetics Digital at Humanetics, architects the technological vision and infrastructure for the company's digital initiatives. Coleman directs the development and implementation of advanced digital platforms that accelerate drug discovery and enhance commercialization strategies. This role involves leading teams focused on data analytics, AI integration, and digital solutions to address urgent market needs. By driving technological innovation, Sandra Coleman ensures that Humanetics leverages cutting-edge digital tools to advance its pipeline of medical countermeasures and radiation modulators. The Chief Technology Officer's expertise is vital for translating complex scientific data into actionable digital insights, supporting the company's mission in oncology and inflammatory lung diseases. Coleman's leadership in digital transformation is key to maintaining Humanetics' competitive edge.